As of Oct 20
| +0.58 / +0.93%|
The 2 analysts offering 12-month price forecasts for Medifast Inc have a median target of 64.50, with a high estimate of 74.00 and a low estimate of 55.00. The median estimate represents a +2.97% increase from the last price of 62.64.
The current consensus among 2 polled investment analysts is to Buy stock in Medifast Inc. This rating has held steady since October, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.